课题基金 / 基金详情

Understanding the Scope and Magnitude of Prescription Drug Diversion

Understanding the Scope and Magnitude of Prescription Drug Diversion
了解处方药转移的范围和程度
批准号:
7502040
负责人:
JAMES A INCIARDI
金额:
$64.73万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-28 至 2011-08-31

项目摘要

项目成果

JAMES A INCIARDI的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): National surveillance systems are documenting widespread, escalating abuse of prescription drugs, and numerous scientific papers have discussed problems associated with pharmaceutical diversion. However, empirical data on the full range of mechanisms, the magnitude of diversion from each source, and the patterns of diversion associated with specific drugs of abuse and/or different at-risk subpopulations are unavailable. Within this context, the overall goal of this 4-year project is to examine and describe the complex of mechanisms and players that connect illicit supplies of prescription drugs (diversion) to abusers in South Florida from three vantage points: 1) prescription drug abusers, 2) prescription drug dealers, and 3) law enforcement. The sampling plan is designed to maximize the diversity of the sample and collect data on the fullest possible range of diversion activities. The specific aims are to:1) recruit samples of 1200 treatment clients (300 publicly-supported, 300 private pay; 300 methadone maintenance clients, and 300 elderly persons ages 60 and above), 300 street drug users, and 300 gay male methamphetamine abusers, all with prescription drug abuse problems; 2) assess life histories of drug abuse, including current alcohol, illicit, and prescription drugs; 3) assess mechanisms of access to and acquisition of prescription drugs; 4) assess demographic, sociocultural, and psychosocial characteristics that are hypothesized to connect prescription drug abusers to their illicit sources of supply; 5) conduct in-depth interviews with sub-samples of 30 respondents from each subgroup; 6) recruit 50 prescription drug sellers from diverse networks and conduct in-depth interviews to determine which prescription drugs they sell, to whom, in what quantities; at what prices, and how they are obtained; 7) extract data from the arrest files of 300 prescription drug traffickers from the diversion unit of the Broward County Sheriff's Department to examine the sources and mechanisms of prescription drug trafficking; and, 8) conduct in-depth interviews with 20 diversion investigators in large police agencies to obtain information about the sources of diverted prescription drugs. Relevance to Public Health. A fuller understanding of the mechanisms and magnitude of prescription drug abuse and diversion, and how they vary across user populations, is critical for health care and regulatory agencies, and industry in order to develop appropriate prevention, risk management, treatment, policy, and enforcement initiatives.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Understanding the Scope and Magnitude of Prescription Drug Diversion
  • 批准号:
    7313342
  • 项目类别:
  • 资助金额:
    $65.34万
  • 财政年份:
    2007
  • 负责人:
    JAMES A INCIARDI
  • 依托单位:
Patterns of Drug Use and Abuse in the Brazilian Rave Culture
  • 批准号:
    7281844
  • 项目类别:
  • 资助金额:
    $2.95万
  • 财政年份:
    2007
  • 负责人:
    JAMES A INCIARDI
  • 依托单位:
Patterns of Drug Use and Abuse in the Brazilian Rave Culture
  • 批准号:
    7460887
  • 项目类别:
  • 资助金额:
    $5.89万
  • 财政年份:
    2007
  • 负责人:
    JAMES A INCIARDI
  • 依托单位:
Prescription Drug Abuse Among Club Drug Users
  • 批准号:
    7107139
  • 项目类别:
  • 资助金额:
    $58.76万
  • 财政年份:
    2005
  • 负责人:
    JAMES A INCIARDI
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: